Completed OBSERVATIONAL NCT04887246

Monitoring the Effectiveness and Safety of COVID-19 Vaccines at National University of Colombia

Monitoring the Effectiveness and Safety of Covid-19 Vaccines in the University Population-National University of Colombia

Sponsor: Universidad Nacional de Colombia

Conditions Covid19 SARS-CoV2 Infection

Interventions COVID-19 vaccines

Updated 6 times since 2021 Last updated: Jul 9, 2024 Started: Mar 15, 2021 Primary completion: Apr 15, 2022 Completion: Dec 15, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Covid19 and SARS-CoV2 Infection and is currently completed. Universidad Nacional de Colombia leads this study, which shows 6 recorded versions since 2021 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Aug 2024 — Sep 2024 [monthly]

Completed

Status: Unknown → Completed
Jul 2024 — Aug 2024 [monthly]

Unknown

Status: Enrolling By Invitation → Unknown
Jul 2022 — Jul 2024 [monthly]

Enrolling By Invitation
Sep 2021 — Jul 2022 [monthly]

Enrolling By Invitation

▶ Show 1 earlier version

Jun 2021 — Sep 2021 [monthly]

Enrolling By Invitation

First recorded

Mar 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Universidad Nacional de Colombia

Data source: Universidad Nacional de Colombia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bogotá, Colombia